ALAN SMIY
Allopathic & Osteopathic Physicians|Family Medicine LENOIR CITY, TN NPI 1114965845
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine TN Novo Nordisk AS All categories
General Payments — all program years on this page
$1,575.09
- Category: General Payments
- Program years: PY2020–2023
- Record count: 102
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $142.59 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $142.59 | 8 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $60.11 | 3 |
| Acerta Pharma LLC | $18.61 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.99 | 1 |
| Nevro Corp. | $16.70 | 1 |
| Lilly USA, LLC | $15.97 | 1 |
| ABBVIE INC. | $14.21 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1000100469 | Bayer Healthcare Pharmaceuticals Inc. | $16.99 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1002543303 | Novo Nordisk Inc | $15.44 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1002543315 | Novo Nordisk Inc | $20.64 | 10/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1002543327 | Novo Nordisk Inc | $24.03 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1015973283 | AstraZeneca Pharmaceuticals LP | $18.61 | 05/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1031235473 | Lilly USA, LLC | $15.97 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1051674019 | Nevro Corp. | $16.70 | 06/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 999057333 | AbbVie Inc. | $14.21 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.